(Q37452991)

English

A pilot study of urokinase-type plasminogen activator (uPA) overexpression in the brush cytology of patients with malignant pancreatic or biliary strictures

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

A pilot study of urokinase-type plasminogen activator (uPA) overexpression in the brush cytology of patients with malignant pancreatic or biliary strictures (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1 reference

based on heuristic

inferred from title

author name string

John F Gibbs

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Michael Schlieman

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Paramvir Singh

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Rakhee Saxena

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Maisie Martinick

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Alan D Hutson

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

James Corasanti

7

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 November 2009

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

2009

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

805971

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

copyright license

Creative Commons Attribution 3.0 Unported

30 November 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

The clinical impact and cost implication of endoscopic ultrasound on use of endoscopic retrograde cholangiopancreatography in a Canadian university hospital

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786994

23 August 2017

Targeting invasion induction as a therapeutic strategy for the treatment of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786994

23 August 2017

Molecular prognostic markers in pancreatic cancer: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786994

23 August 2017

Management strategies for patients with hereditary pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786994

23 August 2017

Risk factors associated with earlier age of onset in familial pancreatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786994

23 August 2017

Endoscopic approach to early diagnosis of pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786994

23 August 2017

Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786994

23 August 2017

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786994

23 August 2017

Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786994

23 August 2017

Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786994

14 September 2017

Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786994

14 September 2017

Demonstration of urokinase expression in cancer cells of colon adenocarcinomas by immunohistochemistry and in situ hybridization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786994

26 June 2018

The urokinase-type plasminogen activator system in cancer metastasis: A review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786994

26 June 2018

Tumour-associated urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity - clinical relevance and prognostic value

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F805971

21 January 2018

Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F805971

21 January 2018

Role of endoscopic ultrasound in diagnosis and therapy of pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F805971

21 January 2018

Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F805971

21 January 2018

Strong prognostic impact of tumor-associated urokinase-type plasminogen activator in completely resected adenocarcinoma of the esophagus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786994

2 September 2018

Proteases as prognostic markers in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19997513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19997513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19997513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase-plasminogen-activator levels and prognosis in 69 soft-tissue sarcomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/19997513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of E-cadherin and uPA and their association with the prognosis of pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19997513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of tissue and blood plasminogen activation system in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19997513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19997513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19997513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of plasminogen activators and their inhibitors in human pancreatic carcinoma: immunohistochemical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19997513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19997513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19997513

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2009/805971

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37452991&oldid=1802090127"